Skip to main content
    L

    Laboratory Corporation of America Holdings (LH)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $325.09
    +7.75 (+2.44%)

    Market Cap: $25.77B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    92%(36/39)
    Avg Surprise
    +10.53%
    Streak
    12 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$4.65
    Range$4.49 - $4.73
    14 analysts
    EPS RevisionsNo revisions (7d)
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$4.60+0.9%
    60d ago$4.65-0.1%
    30d ago$4.65-0.1%
    7d ago$4.65-0.1%
    Current$4.65
    Revenue Consensus
    $3.8B
    Range$3.7B - $3.8B
    12 analysts
    Period ending Dec 31, 2026
    EPS Consensus$4.82
    Range$4.57 - $4.97
    18 analysts
    Revenue Consensus
    $3.8B
    Range$3.7B - $3.8B
    16 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$4.82---
    Sep 26EST
    		-$4.65---
    Jun 26
    Reported Jul 30
    		$4.99$4.79+4.18%Beat+14.7%
    Mar 26
    Reported Apr 30
    		$4.25$4.12+3.16%Beat+10.7%
    Dec 25
    Reported Feb 17
    		$4.07$3.94+3.30%Beat+18.0%
    Sep 25
    Reported Oct 28
    		$4.18$4.14+0.97%Beat+19.4%
    Jun 25
    Reported Jul 24
    		$4.35$4.16+4.57%Beat+10.4%
    Mar 25
    Reported Apr 29
    		$3.84$3.73+2.95%Beat+4.3%
    Dec 24
    Reported Feb 6
    		$3.45$3.39+1.77%Beat+4.5%
    Sep 24
    Reported Oct 24
    		$3.50$3.49+0.29%Beat+3.6%
    Jun 24
    Reported Aug 1
    		$3.94$3.77+4.51%Beat+15.2%
    Mar 24
    Reported Apr 25
    		$3.68$3.48+5.75%Beat-3.7%
    Dec 23
    Reported Feb 15
    		$3.30$3.26+1.23%Beat-20.3%
    Sep 23
    Reported Oct 26
    		$3.38$3.33+1.50%Beat-27.8%
    Jun 23
    Reported Jul 27
    		$3.42$3.45-0.87%Miss-31.0%
    Mar 23
    Reported Apr 25
    		$3.82$3.96-3.54%Miss-37.5%
    Dec 22
    Reported Feb 16
    		$4.14$4.14+0.00%Beat-38.8%
    Sep 22
    Reported Oct 27
    		$4.68$4.68+0.00%Beat-31.4%
    Jun 22
    Reported Jul 28
    		$4.96$4.68+5.98%Beat-19.1%
    Mar 22
    Reported Apr 28
    		$6.11$6.00+1.83%Beat-30.5%
    Dec 21
    Reported Feb 10
    		$6.77$5.80+16.72%Beat-35.9%
    Sep 21
    Reported Oct 28
    		$6.82$4.92+38.62%Beat-18.9%
    Jun 21
    Reported Jul 29
    		$6.13$5.62+9.07%Beat+138.5%
    Mar 21
    Reported Apr 29
    		$8.79$7.49+17.36%Beat+270.9%
    Dec 20
    Reported Feb 11
    		$10.56$8.07+30.86%Beat+269.2%
    Sep 20
    Reported Oct 27
    		$8.41$5.32+58.08%Beat+190.0%
    Jun 20
    Reported Jul 28
    		$2.57$0.99+159.60%Beat-12.3%
    Mar 20
    Reported Apr 29
    		$2.37$1.95+21.54%Beat-9.5%
    Dec 19
    Reported Feb 13
    		$2.86$2.80+2.14%Beat+13.5%
    Sep 19
    Reported Oct 24
    		$2.90$2.85+1.75%Beat+5.8%
    Jun 19
    Reported Jul 25
    		$2.93$2.92+0.34%Beat-1.7%
    Mar 19
    Reported Apr 30
    		$2.62$2.54+3.15%Beat-5.8%
    Dec 18
    Reported Feb 7
    		$2.52$2.49+1.20%Beat+2.9%
    Sep 18
    Reported Oct 24
    		$2.74$2.89-5.19%Miss+11.4%
    Jun 18
    Reported Jul 25
    		$2.98$2.92+2.05%Beat+20.6%
    Mar 18
    Reported Apr 25
    		$2.78$2.63+5.70%Beat+25.2%
    Dec 17
    Reported Feb 6
    		$2.45$2.38+2.94%Beat+14.0%
    Sep 17
    Reported Oct 25
    		$2.46$2.39+2.93%Beat-
    Jun 17
    Reported Jul 26
    		$2.47$2.41+2.49%Beat-
    Mar 17
    Reported Apr 25
    		$2.22$2.20+0.91%Beat-
    Dec 16
    Reported Feb 16
    		$2.15$2.13+0.94%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.89%
    Forward Annual Dividend$2.88
    Payout Ratio14.26%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec
    LH dividend history and ex-dividend datesRun LH in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio18.59EV/EBITDA15.61x
    Price/FCF22.82xFCF Yield4.38%
    Profitability
    Profit Margin6.99%Operating Margin12.20%
    ROE11.70%ROIC8.20%
    Financial Health
    Debt/Equity0.68xInterest Coverage6.42x
    Current Ratio1.80xQuick Ratio1.53x
    Trading Statistics
    Beta0.85Avg Volume749.63K
    52-Week High$341.0652-Week Low$242.07

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$313.88
    SMA 20$312.28
    SMA 50$320.18
    SMA 200$282.27
    EMA 10$315.44
    EMA 20$314.79
    EMA 50$312.49
    EMA 200$288.66

    MACD

    Line: 0.09Signal: -1.50Hist: 1.60

    ADX

    ADX: 14.9+DI: 22.1-DI: 16.1

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down64.0
    PSAR$304.91

    Bollinger Bands

    Upper Band$323.18
    Lower Band$301.39
    %B Position698%(Upper)
    Band Width1.09

    RSI (14-Day)

    Neutral
    62.3

    Momentum Oscillators

    Stoch %K83.8
    Stoch %D77.3
    Williams %R-0.3
    ROC (10d)6.7%
    Momentum20.49
    CCI (20d)179.5
    MFI (14d)86.7

    Volatility Measures

    ATR (14d)$6.81(2.1%)
    StdDev (20d)5.45
    Hist Vol20.4%(Moderate)

    Volume Flow

    VWAP$323.49
    OBV11.6M
    AD Line-80.4M
    CMF (20d)0.061

    Volume Metrics

    Avg Vol (20d)768.5K
    Vol Ratio0.7x
    VWMA (20d)$312.37

    Pivot Points

    R3$325.68
    R2$322.71
    R1$320.03
    Pivot Point$317.06
    S1$314.38
    S2$311.41
    S3$308.73

    Advanced Oscillators

    TSI-0.15
    Ultimate Osc55.7
    KST-28.94

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$3.73B$3.54B$3.52B$3.56B$3.53B$3.35B$3.33B$3.28B$3.22B$3.18B$3.03B$3.06B
    Cost of Revenue$2.62B$2.52B$2.52B$2.54B$2.48B$2.40B$2.43B$2.38B$2.29B$2.28B$2.21B$2.21B
    Gross Profit$1.11B$1.01B$993.20M$1.03B$1.05B$948.00M$896.30M$904.40M$926.40M$897.30M$821.40M$851.20M
    Operating Expenses$660.40M$633.00M$725.60M$628.50M$651.70M$622.00M$679.80M$650.30M$631.60M$576.00M$944.20M$598.90M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$577.20M$551.00M$538.60M$552.40M$579.30M$546.00M$595.20M$568.60M$557.80M$508.40M$532.90M$525.50M
    Operating Income$451.60M$380.80M$267.60M$396.60M$394.50M$326.00M$216.50M$254.10M$294.80M$321.30M$-122,800,000$252.30M
    Interest Income$-600,000$7.10M$-2,600,000$-1,700,000$0$6.20M$14.30M$2.60M$1.00M$3.00M$6.30M$15.60M
    Interest Expense$61.10M$55.10M$55.00M$56.00M$57.10M$56.00M$63.40M$50.40M$47.60M$46.90M$48.80M$50.30M
    Income Before Tax$386.40M$319.70M$190.60M$337.00M$304.70M$275.20M$183.80M$210.60M$267.70M$297.40M$-147,100,000$238.70M
    Income Tax Expense$87.30M$41.70M$25.70M$75.50M$66.40M$62.20M$40.20M$41.00M$62.10M$69.10M$19.70M$55.10M
    Net Income$299.10M$278.00M$164.90M$261.50M$238.30M$213.00M$143.60M$169.60M$205.60M$228.30M$-166,800,000$183.60M
    EBITDA$627.10M$541.00M$272.10M$615.40M$532.10M$491.80M$266.80M$468.00M$515.70M$539.90M$-86,700,000$462.70M
    EBIT$448.10M$367.70M$248.20M$394.70M$361.80M$325.00M$232.90M$258.40M$314.30M$341.30M$-104,600,000$273.40M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LH

    Government Contracts

    Gov Obligations (TTM)
    $1.45M
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    2.8%
    Active Awards
    4
    New Awards (TTM)
    1
    Avg Remaining Term
    5.0 mo

    Top agency: Department of Defense at 96.8% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75D30125P20596Department of Health and Human ServicesCenters for Disease Control and Prevention$46800Sep 23, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Opko Health stock hits 52-week high at 1.75 USD

    Opko Health's stock reached a new 52-week high of $1.75 USD, trading at $1.76 USD with a market capitalization of $1.29 billion. This surge follows a 17% gain over the past week and a 33% increase over six months...

    Investing.com•10/16/26•Somewhat-Bullish

    OPKO Health (NASDAQ:OPK) Stock Rating Raised to Outperform at Barrington Research

    Barrington Research has upgraded OPKO Health (NASDAQ:OPK) from "market perform" to "outperform," setting a $2.25 price target...

    MarketBeat•10/16/26•Somewhat-Bullish

    PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains?

    PACS Group, Inc. (PACS) shares rose 6.2% on increased volume, reflecting investor optimism ahead of its Q3 2026 financial results. The company is projected to report an 8.1% revenue growth and 75% earnings growth...

    Yahoo Finance•10/16/26•Somewhat-Bullish

    Labcorp To Pay Up To $872M For BioReference Health Assets, Including 4Kscore Prostate Test

    Labcorp has agreed to acquire specific BioReference Health assets, including labs, patient service centers, and the FDA-approved 4Kscore prostate cancer test...

    Medtech Insight•10/16/26•Bullish

    Labcorp Holdings (LH) Rolls Out Thrive 5 And Posts Solid Results, Is It Fully Priced?

    Labcorp Holdings (LH) has launched the Thrive 5 Health Test and reported strong quarterly results, indicating a push into cardiometabolic screening and ongoing commercial relevance for its diagnostics. Despite recent...

    Simply Wall Street•10/15/26•Somewhat-Bullish

    LH Valuation and Fair Value

    P/E
    18.6x
    Forward P/E
    16.2x
    EV/EBITDA
    15.6x
    P/FCF
    22.8x
    PEG
    1.2x
    P/B
    3.1x
    See GNG's fair value

    LH Profitability: Margins, ROIC and FCF

    Gross margin
    28.9%
    Operating margin
    12.2%
    Net margin
    7.0%
    ROIC
    8.2%
    ROE
    11.7%
    FCF margin
    8.1%
    FCF yield
    4.4%

    LH Competitors

    CompanyTicker
    West Pharmaceutical Services IncWST
    Quest Diagnostics IncorporatedDGX
    Zoetis IncZTS
    Roivant Sciences LtdROIV
    GE HealthCare Technologies Inc.GEHC
    Koninklijke Philips NV ADRPHG
    DexCom IncDXCM
    United Therapeutics CorporationUTHR

    Sector: Healthcare

    LH Analyst Ratings

    Consensus
    Buy
    Analysts
    18
    Strong Buy
    2
    Buy
    11
    Hold
    4
    Sell
    0
    Strong Sell
    1

    LH Bull Case vs Bear Case

    Bull case

    • LH beat EPS estimates in 100.0% of its last 8 reported quarters.
    • 72.2% of LH's analyst ratings are Buy or Strong Buy.

    LH Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    2.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $4.65
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 1 down

    LH Dividend

    Forward yield
    0.9%
    Payout ratio
    14.3%
    Pay months
    Mar, Jun, Sep, Dec
    LH dividend history

    Frequently Asked Questions About LH

    What is LH's current dividend yield?

    Laboratory Corporation of America Holdings (LH) has a forward dividend yield of 0.89%.

    Does LH pay dividends?

    Yes, Laboratory Corporation of America Holdings pays dividends with a forward dividend yield of 0.89%.

    What is LH's P/E ratio?

    Laboratory Corporation of America Holdings has a price-to-earnings (P/E) ratio of 18.59.

    What is LH's market cap?

    Laboratory Corporation of America Holdings (LH) has a market capitalization of $25.77B with a current stock price of $325.09.

    Related stocks

    Sector: Healthcare

    All stocks starting with L

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In